Gazda, Thomas D., M.D., PC

Quick facts

Marketed products

• Abilify Maintena · Psychiatry
  Abilify Maintena is a long-acting intramuscular injection of aripiprazole that acts as a dopamine D2 receptor partial agonist to treat schizophrenia and bipolar disorder.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Gazda, Thomas D., M.D., PC portfolio CI brief
• Gazda, Thomas D., M.D., PC pipeline updates RSS